chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within 6-12 hours of 2nd dose, entire body felt sour.   Sour head, sour body. Every day, every night for a month. Persistent lethargy, awakening at 2am feeling unwell (in a weird way, not flu-ish)  I am simply no longer well. It feels possibly heart-related, circulatory?
extreme fatigue, brain fog, body aches, swelling at the injection site, swelling of tongue, difficulty speaking, memory loss day after, constant need to sleep and lapse of memory, weakness
1 day after vaccine mild redness at vaccination site. Over the course of the day increasing redness, swelling, firmness to the touch and overlying warmth at the vaccination site (presented 30 hours after vaccination). No evidence of cellulitis given presentation close to administration timing - likely adverse reaction. Recommended ibuprofen or tylenol and ice. Will have triage RN f/u with parent tomorrow to evaluate improvement or progression. If symptoms progressing will consider antibiotic therapy for potential celllulitic reaction.
Complained of redness, swelling, and itching at injection site.  Arm was warm to touch.
Initial information received on 19-Nov-2018 regarding an unsolicited valid non-serious case received from a consumer. This case involves female patient who experienced short of breath, allergic reaction, hives on her back and jaw, burns and itches, while she received vaccine INFLUENZA VACCINE. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 07-Nov-2018, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number not reported via unknown route in unknown administration site). On an unknown date, the patient developed a non-serious short of breath, allergic reaction, hives on her back and jaw, burns and itches and burns and itches, following the administration of INFLUENZA VACCINE. (Other relevant tests included No lab data.) Final diagnosis was burns and itches, hives on her back and jaw, allergic reaction and short of breath. It was not reported if the patient received a corrective treatment. On an unknown date, the patient outcome for all the events was not reported. List of document held by sender: None. Follow up information recieved from consumer on 19-Nov-2018. No additional information recieved.
Within 5 minutes of vaccines, had vomiting, redness to skin, swollen lip and itching, gave EPI and BENADRYL and sent to ER for anaphylaxis reaction.
PNEUMOV AX 23 was administered to patient while patient received a prior dose a month ago; PNEUMOV AX 23 was administered to patient while patient received a prior dose a month ago. The error occurred during dispensing; This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent conditions, known allergies and concomitant medications was not provided.      On an unknown date, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (strength, dose, route of administration, lot # and expiration date were not provided) for prophylaxis, an the next dose of the mentioned vaccine, was administered approximately after month ago (date unspecified). No further information was provided.         This is a non valid report as patient's identifiers were not provided.  Follow up information has been received on 08-SEP-2020 from a registered pharmacist referring to a 67 year old female patient.  On 28-JUL-2020 ( reported as "prior dose a month ago"), the patient was vaccinate with a first dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) (dose information, route of administration, lot # and expiration date were not reported) for prophylaxis. On 27-AUG-2020, the patient was vaccinated with a second dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23), intramuscularly, lot # S029916, expiration date not reported but upon internal validation established as 12-JUN-2021 for prophylaxis.  Concomitant therapies included zoster rge vaccine (mammalian)(SHINGRIX), influenza virus sag 4v vaccine inactivated(FLUAD QUADRIVALENT) and diphtheria toxoid, pertussis acellular 3-component vaccine, tetanus toxoid(BOOSTRIX) administered on the same date. The medication error ouccurred during dispensing.  This case was previously considered non-valid, but upon receipt of follow-up patient's identifiers were provided. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.  devicelotnumber: S029916; expirationdate: 12-JUN-2021; deviceage and unit: 0 ; operatorofdevice: Pharmacist; malfunction: Unknown; productavailableforevaluation: No; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
Left thigh- had urticarial rash develop within 5 minutes of administration of vaccine (MMR & Prevnar) treated with Benadryl oral & cold pack- No respiratory distress, no vital signs.
From initial information received on 4/28/04 from the patient regarding an adverse event occurring in the USA, it was reported that the 34 year old female patient received her fourth dose of IMOVAX RABIES from a post-exposure series, administered in the right upper arm on 2/25/04 PM. The vaccine lot number and route of administration were not reported. One and a half hour later, the patient developed flu-like symptoms as well as redness and soreness in her right arm. The patient received her third dose of IMOVAX RABIES, administered in the right upper arm in January of 2004 with no reactions reported. She also received her fifth dose of the vaccine, administered in the left upper arm on 2/28/04 and experienced the same reaction as after her fourth dose. Lot numbers and routes of administration for the third or fifth doses of IMOVAX RABIES were not reported. Reportedly, the patient recovered from these events.
soreness in site of injection; fatigue; This is a spontaneous report from a contactable consumer (patient). A 32-year-old non-pregnant female patient received bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE; lot number: EL9262; expiration date: unknown), via an unspecified route of administration left arm on 24Jan2021 11:45 at a single dose for covid-19 immunisation. Medical history included IBS (irritable bowel syndrome) and hypercholesterolaemia. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medication included rosuvastatin calcium (CRESTOR). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had soreness in site of injection and fatigue on 24Jan2021 14:00. The events were reported as non-serious. No treatment was received for the adverse event. The patient has not been tested for COVID-19 since the vaccination. The outcome of the events was recovering.
Information has been received from a licensed practical nurse concerning a 20 year old female patient with environmental allergies who on 10-NOV-2009 was intramuscularly vaccinated with the first dose of GARDASIL (Lot#660612/0229X) 0.5 mL. Concomitant therapy included ORTHO TRI-CYCLEN LO and albuterol inhaler as needed. The licensed practical nurse reported that 7 days after received GARDASIL, on 17-NOV-2009, the patient experienced dizziness, nausea and a rash on her face, neck and arms. In November 2009 the patient sought her family physician and she was diagnosed with vertigo and eczema. On an unspecified date, the patient had recovered. The licensed practical nurse reported that now, on 21-JAN-2010, the patient reported her that she had bumps on her arms, but none were observed during the office visit. Additional information has been requested.
nausea; diarrhea; arm  pain; This spontaneous report was received from a nurse and refers to a 22-year-old female patient with depression and polycystic ovaries. The patient was not pregnant, she had no drug reactions or allergies. Concomitant therapies included birth control pills (unspecified), escitalopram oxalate (LEXAPRO), propranolol and topiramate (TOPAMAX).   On 28-OCT-2019, the patient was vaccinated with a first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) intramuscularly, expiration date 28-NOV-2021 (exact dose was not reported) (lot number 162196 is an invalid lot number for hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9)) for prophylaxis.  On an unknown date in 2019, after receiving the injection, the patient experienced nausea, diarrhea and arm pain. The nurse reported that "the arm pain continued and was being watched by the patient's primary care provider." There was no treatment given for the adverse events. The patient sought medical attention and called primary care provided.  The outcome of nausea, pain in extremity and diarrhoea was unknown. The relatedness between the events and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was not reported.
Pt recvd 2nd Hep B vax on 11JUN92 on the AM of 12JUN92 c/o sx of edema around both eyes; felt like was having an allergy attack; stomach cramps;
flu; muscle pain; weakness; This case was reported by a consumer via interactive digital media and described the occurrence of influenza in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced influenza, muscle pain and weakness. On an unknown date, the outcome of the influenza, muscle pain and weakness were unknown.   It was unknown if the reporter considered the influenza, muscle pain and weakness to be related to Shingrix.     Additional Information: GSK Receipt Date: 23-JUN-2022 Reporter's Comments: This case was received from patient's cousin via interactive digital media. The reporter stated that the patient develops flu, severe muscle pain & weakness after receiving the vaccine. The reporter want to know how long can it last. The follow-up would not possible as no contact details were available.
Pt seen 5/27/10 chief complaint red bump on left leg upon exam found shot site red and 2 chicken pox on body.
Rash started on 1/6 around the injection site. Developed into L axillary lymphadenopathy, fatigue, myalgias, and headache. Erythema does recede with benadryl but does not resolve. was a little wheezy on 1/6. She has h/o anaphylaxis due to latex and has an epi pen
Pfizer 6m-4yo bivalent  covid vaccine given to patients for their third dose who received two moderna doses for their primary series. No adverse effects. Per CDC they said patients do not need to be revaccinated and are still considered up to date.
The day of the shot her arm started hurting. The next day it swelled up and turned red, she had a tough time getting her ring off her fingers were swollen. Since then the pain is better; swelling is decreased.
Shingles - Has recurred about 15 times. Valtrex/Gabapentin.
Flu-like symptoms for the first 4 days (body extremely sore all over), then turned into headache for next 4 days (today).
Patient's arm swelled up around vaccination site requiring several trips to the ER and a prescription for Bactrim DS.
Flu like symptoms; Muscle cramps; Headache; A spontaneous report was received on 9 Feb 2021, from a consumer concerning a 65-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events headache, flu.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 30 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: Unknown) intramuscularly for prophylaxis of COVID-19 infection.  On 1 Feb 2021, the patient experienced the event(s) headache, flu.  Treatment details included Tylenol, Product Product Description Product Detail Category Topic.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), headache, flu was unknown.
The night after the vaccine I experienced dizziness and numbness in my lips. To this day my lips are still numb and I am still suffering with vertigo. I don?t know if this was from the vaccine, but I was a perfectly healthy 44 year old before I had the vaccine. I never had any issues with vertigo before that night.
Moderna vial with BUD 2/12/22 was given to Covid Vaccine Clinic on morning of 2/14/22. Booster 4th dose for immunocompromised individuals was administered to patient at 0901 this AM. Error was discovered at 0915 when doing daily routine vaccine inventory. Expired vials quarantined. Moderna contacted and awaiting further guidance. Reporting via VAERS.
Threw up; started chilling; Started burning up late in night or early morning on 5/4.; Hot and cold through out the morning; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 03May2021 at 11:15 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included covid-19 on an unspecified date. Concomitant medications included ramipril (MANUFACTURER UNKNOWN) from an unknown date for an unspecified indication. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 12Apr2021 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04May2021 the patient experienced started burning up late in night or early morning. On the same day around 06:45 started chilling and on the same day around 09:15 threw up. On the same day hot and cold through-out the morning. The clinical outcome of the events feeling hot, chills, vomiting, feeling hot and cold was not recovered.  No follow-up attempts are needed. No further information is expected.
I feel a tingling sensation in my left arm down to my wrist and in my side and a bit in my upper leg.  Never had any reaction like this to a flu shot.  Felt it was important to report immediately.  Had shot at 3:45pm today approx.
Pt. developed a reaction to 1st dose of COVID-19 vaccine.  Pt. described symptoms as having fast heartbeat and dizziness.  No meals taken prior to administration of vaccine.  No hospital care provided.  V/S: 104/71, P 85, T 97, O2Sat 97%, standing B/P 110/76, P 85, Blood sugar 96.
Td was mistakenly administered as a PPD test.  Patient experienced redness and induration at the injection site.
Patient described arm post vaccination as very red, warm to the touch, swollen, hard to move the arm. Began 1 day post vaccination. Began to improve by second day post vaccination. Patient's physician told her to report to pharmacy.
patient now complaining of fatigue; tremors began in the left arm the evening; Initial information received on 10-Nov-2020 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 78 years old female patient who experienced tremors began in the left arm the evening and patient now complaining of fatigue, while she received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's medical history included Vaccination site nerve damage. The patient's past medical treatment(s), vaccination(s) and family history were not provided.    On 08-Nov-2020, the patient received a dose of 0.5 ml suspect INFLUENZA QUADRIVAL A-B VACCINE (lot UT7096NA) via intramuscular route in the right arm for prophylactic vaccination.  On 09-Nov-2020, the patient developed a non-serious tremors in the left arm the evening (tremor) 1 day following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  On an unknown date, the patient developed a non-serious patient now complaining of fatigue (Unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  It was not reported if the patient received a corrective treatment. The outcome was reported as unknown for both events.
sick for 2 weeks; Initial information received on 31-Jan-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves Adult of an unknown gender patient who experienced sick for 2 weeks ,while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (unknown dose, formulation, via unknown route in unknown administration site) as prophylactic vaccination.  On an unknown date, the patient reported made me sick for 2 weeks (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (sick for 2 weeks).  At time of reporting, the outcome was Unknown for the event sick for 2 weeks.; Reporter's Comments: Made me sick for 2 weeks
Rash/hives started on neck and chest. It spread over full body including palms, soles of feet, ears and scalp. After 3 days of rash and hives and when face and neck started swelling, went to ER. Hives responded to oral steroids and antihistamines. Rash diminished over 10 days, but I still have very pronounced dermatographia on thighs and trunk, especially at night.
Localized reaction to Tetanus and Diphtheria toxoid absorbed measured 4 x 2-3", raised approx one inch, reddened, painful and hard. Low grade temp 99's. C/O headache and above symptoms from  6/14 - 06/16/2005. On 06/20/2005 site 1cm x 1cm hard and tender.
Quite severe metal taste in mouth beginning day after vaccine.  Still remaining on day 11 after. Limited appetite due to taste changes.
Left thigh is red, painful, swollen 5 x 3.5 pain deals with upper injection
within 24 hours of shot local reaction of red/induration but also with a large central  area of blisters with serosanguinous discharge; 6x5 cm total area  4x2 cm area blisters.
Patient fainted, hit his head on the floor upon falling, within 2-3 minutes after standing after flu vaccination.
Medics called @14:20 to respond for patient evaluation due to persistent tachycardia, continued nausea, intermittent dizziness (stated she felt "light-headed") and report of occasional palpitations. Pt blood glucose 150@1426. Medics arrival @1430 and pt encouraged to be evaluated and followup at hospital, pt agreeed to be evaluated in ambulance (@1438 EKG-sinus tachycardia @120, BG @175) but declined transport to hospital. Pt husband provided with instruction on OTC nausea treatment including diet and hydration. Pt and spouse advised to call 911 or respond to hospital if symptoms persisted or worsened, both verbalized understanding.
Dizziness would come and go after the first shot; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness would come and go after the first shot) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included Anemic.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced DIZZINESS (Dizziness would come and go after the first shot). At the time of the report, DIZZINESS (Dizziness would come and go after the first shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported. Treatment medications were not reported.   This case was linked to MOD-2021-326086 (Patient Link).
After getting the first dose and after three minutes I feel*dizziness and my heart rate is getting low and my ass reflux is coming up. I tried to drive home but I could not able to do it. My husband came in he picked me.On the facility they said my ass reflux is causing my all the problems I came home and take his reflux medicines and doing rest in 1 to 2 days I getting better.  But after three days my face getting swell and my lips get swell my throat gets well from inside too. My body start eating and on the aging spot on my arm and knee I had patches. I went to my primary care and my primary care said to me I might have a COVID-19 Pfizer vaccination reaction because my routine remains same as before nothing anything new medicine added to my routine. My primary care give me prednisone and Zyrtec. After getting prednisone and after a week I feels better myself.  I am not sure should I go for second doors or not please advise me if you can and and report my problem after vaccination thank you so much
18 week old pt received vaccine in right leg. reports swelling at injection site, erythema and pain at injection site. Mother reports similar experience in January 2000 post vaccine.
Fever; Flu like symptoms; Swollen lymph nodes; Threw up; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via unspecified route of administration in left arm on 17Mar2021 at 18:00 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via unspecified route of administration in the left arm on 24Feb2021 at 18:00 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. The patient did not have any other medical history and any known allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included LEXAPRO (escitalopram oxalate), metformin, YAZ (drospirenone, ethinylestradiol betadex clathrate), ZYRTEC (cetirizine hydrochloride), Vitamin b12 (cyanocobalamin), Vitamin d3 (colecalciferol), all taken for unknown indications from unknown dates. On 18Mar2021 at 05:00, 11 hours after vaccination, the patient threw up and had fever and flu like symptoms for the following 18 hours at 23:00 and also swollen lymph nodes. The patient did not receive treatment for vomiting, fever, flu like symptoms and swollen lymph nodes. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of vomiting, fever, flu like symptoms and swollen lymph nodes was recovered on an unspecified date.   Information about lot/ batch number cannot be obtained. No further information is expected.  Amendment: This follow-up report is being submitted to amend previously reported information: concomitant drug updated, event onset time for events fever, flu like symptoms and swollen lymph nodes updated to 18Mar2021 23:00 and narrative updated accordingly.
Patient described fast heart rate and irregular. Stated she gets it with all allergies and frequently Given requested benadryl 25 mg po with resolution of symptoms